$7.11
Insights on Clarivate Plc
Revenue is up for the last 2 quarters, 647.2M → 683.7M (in $), with an average increase of 5.3% per quarter
Netprofit is down for the last 2 quarters, 12.3M → -843.9M (in $), with an average decrease of 6961.0% per quarter
In the last 1 year, International Business Machines Corp. has given 45.3% return, outperforming this stock by 65.4%
In the last 3 years, International Business Machines Corp. has given 27.9% return, outperforming this stock by 100.4%
0.21%
Downside
Day's Volatility :1.18%
Upside
0.97%
14.63%
Downside
52 Weeks Volatility :39.48%
Upside
29.11%
Period | Clarivate Plc | Sector (Industrials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -19.59% | 9.4% | 0.0% |
6 Months | 7.53% | 24.3% | 0.0% |
1 Year | -20.13% | 22.0% | -1.1% |
3 Years | -72.86% | 21.2% | -22.1% |
Market Capitalization | 4.8B |
Book Value | $6.91 |
Earnings Per Share (EPS) | -1.47 |
PEG Ratio | 0.3 |
Wall Street Target Price | 8.39 |
Profit Margin | -34.66% |
Operating Margin TTM | 13.87% |
Return On Assets TTM | 1.29% |
Return On Equity TTM | -14.23% |
Revenue TTM | 2.6B |
Revenue Per Share TTM | 3.91 |
Quarterly Revenue Growth YOY | 1.2% |
Gross Profit TTM | 1.7B |
EBITDA | 983.0M |
Diluted Eps TTM | -1.47 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.74 |
EPS Estimate Next Year | 0.8 |
EPS Estimate Current Quarter | 0.21 |
EPS Estimate Next Quarter | 0.18 |
What analysts predicted
Upside of 18.0%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 968.5M | ↑ 5.54% |
Net Income | -242.2M | ↓ 8.25% |
Net Profit Margin | -25.0% | ↑ 3.76% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 29.49% |
Net Income | -106.3M | ↓ 56.1% |
Net Profit Margin | -8.48% | ↑ 16.52% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 0.0% |
Net Income | -106.3M | ↑ 0.0% |
Net Profit Margin | -8.48% | ↑ 0.0% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.7B | ↑ 112.1% |
Net Income | -4.0B | ↑ 3625.14% |
Net Profit Margin | -148.89% | ↓ 140.41% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.7B | ↑ 0.0% |
Net Income | -4.0B | ↑ 0.0% |
Net Profit Margin | -148.89% | ↑ 0.0% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 2.6B | ↓ 1.17% |
Net Income | -911.2M | ↓ 76.99% |
Net Profit Margin | -34.66% | ↑ 114.23% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 629.1M | ↓ 8.37% |
Net Income | 43.5M | ↓ 30.29% |
Net Profit Margin | 6.91% | ↓ 2.18% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 668.8M | ↑ 6.31% |
Net Income | -123.1M | ↓ 382.99% |
Net Profit Margin | -18.41% | ↓ 25.32% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 629.1M | ↓ 5.94% |
Net Income | 43.5M | ↓ 135.34% |
Net Profit Margin | 6.91% | ↑ 25.32% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 668.8M | ↑ 6.31% |
Net Income | -123.1M | ↓ 382.99% |
Net Profit Margin | -18.41% | ↓ 25.32% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 647.2M | ↓ 3.23% |
Net Income | 12.3M | ↓ 109.99% |
Net Profit Margin | 1.9% | ↑ 20.31% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 683.7M | ↑ 5.64% |
Net Income | -843.9M | ↓ 6960.98% |
Net Profit Margin | -123.43% | ↓ 125.33% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 3.7B | ↓ 7.38% |
Total Liabilities | 2.7B | ↓ 2.2% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 15.2B | ↑ 309.67% |
Total Liabilities | 5.6B | ↑ 110.73% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 15.2B | ↑ 0.0% |
Total Liabilities | 5.6B | ↑ 0.0% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 13.9B | ↓ 8.24% |
Total Liabilities | 7.1B | ↑ 27.29% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 13.9B | ↑ 0.0% |
Total Liabilities | 7.1B | ↑ 0.0% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 12.7B | ↓ 8.88% |
Total Liabilities | 6.7B | ↓ 5.86% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 13.9B | ↓ 26.0% |
Total Liabilities | 7.0B | ↓ 10.46% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 13.7B | ↓ 1.68% |
Total Liabilities | 6.8B | ↓ 3.05% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.9B | ↑ 1.71% |
Total Liabilities | 7.0B | ↑ 3.15% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.7B | ↓ 1.68% |
Total Liabilities | 6.8B | ↓ 3.05% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.4B | ↓ 2.1% |
Total Liabilities | 6.7B | ↓ 0.46% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 12.7B | ↓ 5.3% |
Total Liabilities | 6.7B | ↓ 0.32% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -26.1M | ↓ 491.48% |
Investing Cash Flow | 11.9M | ↓ 129.68% |
Financing Cash Flow | -32.6M | ↓ 242.89% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 263.5M | ↓ 1109.58% |
Investing Cash Flow | -140.9M | ↓ 1280.53% |
Financing Cash Flow | 2.9B | ↓ 9075.86% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 323.8M | ↑ 22.87% |
Investing Cash Flow | -3.0B | ↑ 2023.84% |
Financing Cash Flow | 4.0B | ↑ 37.78% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 509.3M | ↑ 57.3% |
Investing Cash Flow | -3.0B | ↓ 0.11% |
Financing Cash Flow | -759.2M | ↓ 118.83% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 509.3M | ↑ 0.0% |
Investing Cash Flow | 57.3M | ↓ 101.92% |
Financing Cash Flow | -759.2M | ↑ 0.0% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 227.5M | ↑ 134.05% |
Investing Cash Flow | -67.4M | ↑ 11.04% |
Financing Cash Flow | -151.6M | ↑ 0.66% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 162.4M | ↓ 28.62% |
Investing Cash Flow | 228.1M | ↓ 438.43% |
Financing Cash Flow | -46.2M | ↓ 69.53% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 227.5M | ↑ 40.09% |
Investing Cash Flow | -60.4M | ↓ 126.48% |
Financing Cash Flow | -151.6M | ↑ 228.14% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 162.4M | ↓ 28.62% |
Investing Cash Flow | -47.1M | ↓ 22.02% |
Financing Cash Flow | -46.2M | ↓ 69.53% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 163.4M | ↑ 0.62% |
Investing Cash Flow | -62.9M | ↑ 33.55% |
Financing Cash Flow | -124.4M | ↑ 169.26% |
Sell
Neutral
Buy
Clarivate Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Clarivate Plc | -0.97% | 7.53% | -20.13% | -72.86% | -73.88% |
Accenture Plc | -5.09% | 7.0% | 14.28% | 9.43% | 75.23% |
Fiserv, Inc. | -0.89% | 34.6% | 32.47% | 22.79% | 79.58% |
International Business Machines Corp. | -3.5% | 32.22% | 45.29% | 28.69% | 30.18% |
Fidelity National Information Services | 1.14% | 42.38% | 28.71% | -53.26% | -35.83% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Clarivate Plc | 37.25 | NA | 0.3 | 0.74 | -0.14 | 0.01 | NA | 6.91 |
Accenture Plc | 28.78 | 28.78 | 2.19 | 12.1 | 0.27 | 0.13 | 0.02 | 43.13 |
Fiserv, Inc. | 29.88 | 29.88 | 1.02 | 8.63 | 0.1 | 0.03 | NA | 50.26 |
International Business Machines Corp. | 22.32 | 22.32 | 4.2 | 10.08 | 0.34 | 0.05 | 0.04 | 24.63 |
Fidelity National Information Services | 83.88 | 83.88 | 6.01 | 4.72 | 0.02 | 0.02 | 0.03 | 32.75 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Clarivate Plc | Buy | $4.8B | -73.88% | 37.25 | -34.66% |
Accenture Plc | Buy | $199.2B | 75.23% | 28.78 | 10.89% |
Fiserv, Inc. | Buy | $87.6B | 79.58% | 29.88 | 16.07% |
International Business Machines Corp. | Hold | $166.8B | 30.18% | 22.32 | 12.13% |
Fidelity National Information Services | Buy | $41.1B | -35.83% | 83.88 | -67.75% |
LEONARD GREEN PARTNERS LP
EXOR NV
Clarkston Capital Partners, LLC
Impactive Capital LP
Generation Investment Management LLP
Partners Group Holding AG Junk
clarivate analytics is the global leader in providing trusted insights and analytics to accelerate the pace of innovation. we offer some of the most trusted brands across the innovation lifecycle, including web of science™, cortellis™, derwent™, compumark™, markmonitor® and techstreet™. organizations and researchers rely on the curated knowledge bases from clarivate for information about scientific and academic research, patent analytics, pharmaceutical and biotech intelligence and ip management. an independent company with over 4,000 employees and operations in more than 100 countries, clarivate is on a bold entrepreneurial mission to help radically reduce the time from new ideas to life-changing innovations. for more information, please visit clarivate.com.
Organization | Clarivate Plc |
Employees | 12000 |
CEO | Mr. Jonathan Gear |
Industry | Industrial goods |